HUP0100080A3 - Use of mirtazapine for producing pharmaceutical compositions for treating sleep apneas - Google Patents

Use of mirtazapine for producing pharmaceutical compositions for treating sleep apneas

Info

Publication number
HUP0100080A3
HUP0100080A3 HU0100080A HUP0100080A HUP0100080A3 HU P0100080 A3 HUP0100080 A3 HU P0100080A3 HU 0100080 A HU0100080 A HU 0100080A HU P0100080 A HUP0100080 A HU P0100080A HU P0100080 A3 HUP0100080 A3 HU P0100080A3
Authority
HU
Hungary
Prior art keywords
mirtazapine
pharmaceutical compositions
treating sleep
producing pharmaceutical
sleep apneas
Prior art date
Application number
HU0100080A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HUP0100080A2 publication Critical patent/HUP0100080A2/hu
Publication of HUP0100080A3 publication Critical patent/HUP0100080A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU0100080A 1997-11-14 1998-11-13 Use of mirtazapine for producing pharmaceutical compositions for treating sleep apneas HUP0100080A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203548 1997-11-14
PCT/EP1998/007330 WO1999025356A1 (en) 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas

Publications (2)

Publication Number Publication Date
HUP0100080A2 HUP0100080A2 (hu) 2001-08-28
HUP0100080A3 true HUP0100080A3 (en) 2002-05-28

Family

ID=8228923

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100080A HUP0100080A3 (en) 1997-11-14 1998-11-13 Use of mirtazapine for producing pharmaceutical compositions for treating sleep apneas

Country Status (20)

Country Link
US (1) US6303595B1 (cs)
EP (1) EP1030667B1 (cs)
JP (1) JP2001522891A (cs)
KR (1) KR20010032009A (cs)
CN (1) CN1154495C (cs)
AT (1) ATE289816T1 (cs)
AU (1) AU737590B2 (cs)
BR (1) BR9815098A (cs)
CA (1) CA2309744A1 (cs)
CZ (1) CZ296282B6 (cs)
DE (1) DE69829202T2 (cs)
DK (1) DK1030667T3 (cs)
ES (1) ES2238781T3 (cs)
HU (1) HUP0100080A3 (cs)
IL (2) IL135825A0 (cs)
NO (1) NO20002218L (cs)
PL (1) PL192272B1 (cs)
PT (1) PT1030667E (cs)
TR (1) TR200001293T2 (cs)
WO (1) WO1999025356A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
DK1066036T3 (da) * 1998-02-27 2006-08-21 Univ Illinois Midler med serotoninrelateret aktivitet til behandling af sövnapnö
BR0108261A (pt) * 2000-02-11 2003-03-05 Akzo Nobel Nv Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono
US20020183306A1 (en) * 2001-05-30 2002-12-05 Pfizer Inc. Combination treatment for sleep disorders including sleep apnea
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
WO2005023767A2 (en) 2003-09-10 2005-03-17 Brentwood Equities Ltd. Diastereomers of 4-aryloxy-3-hydroxypiperidines
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
EP1827450A4 (en) * 2004-11-17 2009-04-22 Cypress Bioscience Inc METHOD FOR REDUCING THE SIDE EFFECTS OF TREATMENT WITH MIRTAZAPINE
CN101132777A (zh) 2004-12-20 2008-02-27 科利吉姆制药公司 用于睡眠障碍的药物组合物
CN101679431B (zh) 2007-04-11 2013-08-14 Msd欧斯股份有限公司 制备四环苯并氮杂卓的对映异构体的方法
EP2167096A4 (en) * 2007-06-13 2010-07-14 Cypress Bioscience Inc IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM
EP2861244B1 (en) * 2012-06-14 2018-09-19 The Regents Of The University Of Michigan Sleep apnea treatment
WO2016138357A1 (en) 2015-02-27 2016-09-01 Kindred Biosciences, Inc. Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
EP0517984A1 (en) 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
DE69636393T2 (de) * 1995-10-24 2006-12-07 Grünenthal GmbH Montirelin zur verhinderung der schlafapnoe
SE9504537D0 (sv) * 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent

Also Published As

Publication number Publication date
JP2001522891A (ja) 2001-11-20
EP1030667A1 (en) 2000-08-30
CZ296282B6 (cs) 2006-02-15
NO20002218L (no) 2000-05-12
AU737590B2 (en) 2001-08-23
CA2309744A1 (en) 1999-05-27
EP1030667B1 (en) 2005-03-02
IL135825A (en) 2006-12-31
US6303595B1 (en) 2001-10-16
DK1030667T3 (da) 2005-06-20
WO1999025356A1 (en) 1999-05-27
CZ20001751A3 (cs) 2000-10-11
NO20002218D0 (no) 2000-04-28
IL135825A0 (en) 2001-05-20
AU1754899A (en) 1999-06-07
KR20010032009A (ko) 2001-04-16
PT1030667E (pt) 2005-06-30
ATE289816T1 (de) 2005-03-15
PL340467A1 (en) 2001-02-12
DE69829202D1 (de) 2005-04-07
HK1029932A1 (en) 2001-04-20
DE69829202T2 (de) 2005-07-21
PL192272B1 (pl) 2006-09-29
CN1154495C (zh) 2004-06-23
TR200001293T2 (tr) 2002-09-23
BR9815098A (pt) 2000-10-10
ES2238781T3 (es) 2005-09-01
HUP0100080A2 (hu) 2001-08-28
CN1278731A (zh) 2001-01-03

Similar Documents

Publication Publication Date Title
HUP9701059A3 (en) Use of strontium salts for the production of pharmaceutical compositions intended for the treatment of arthrosis
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
HUP9903489A3 (en) Use of epinastine for the preparation of pharmaceutical compositions treating pain
HUP0102556A3 (en) Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
HUP0103386A3 (en) Use of quinazoline derivatives for producing pharmaceutical compositions having jak 3-inhibitor effect
HUP0200819A3 (en) Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
HU9800535D0 (en) Use of pyrimidine derivatives for producing pharmaceutical compositions for preventing tumor
IL138129A (en) Composition for therapy of estrogen-associated disorders
IL132760A0 (en) Vibrator for treatment of constipation
HUP9900386A3 (en) Use of phenoxy-pyridine derivatives for producing pharmaceutical compositions suitable for treating heart failure
HUP0100080A3 (en) Use of mirtazapine for producing pharmaceutical compositions for treating sleep apneas
HUP0201187A3 (en) Use of ecteinascidin743 for producing pharmaceutical compositions suitable for treating cancer
HUP0200553A3 (en) Use of pyridine derivatives as mglur5 antagonists producing pharmaceutical compositions suitable for the treatment of pain and anxiety
HUP0100170A3 (en) N-benzyl-3-indenylacetamides derivatives and use of them for producing pharmaceutical compositions for treating neoplasia
PL315666A1 (en) Heterocyclic compounds of therapeutic properties
HUT74187A (en) 3-phenyl-izoquinolin-(2h)-one derivatives, process for producing them and use of them for producing pharmaceutical compositions
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
HUP9904638A3 (en) Use of benzopyrane derivatives for production of pharmaceutical compositions
HUP0204391A3 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
HUP0202371A3 (en) Diacylhydrazine derivatives, process for producing them, use of these derivatives for producing of pharmaceutical compositions and pharmaceutical compositions
HUP9801894A3 (en) Use of dofetilide for the preparation of pharmaceutical compositions treating congestive heart failure
HUP0003803A3 (en) Use of flunarizine for producing pharmaceutical compositions useful for the topical treating of glaucoma
HUP9801925A3 (en) Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons
IL130831A (en) Imino-aza-anthrayclinone derivatives, process for their preparation and pharmaceutical compositions comprising them for the treatment of amyloidosis

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: N.V. ORGANON, NL

Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished